Fig. 4From: SwissMTB: establishing comprehensive molecular cancer diagnostics in Swiss clinicsReport section for therapies potentially lacking benefit. Gene name and variant type, as well as observed frequency, copy number, or gene expression are presented to indicate resistance-causing events. Furthermore, details on the affected therapy, as well as a brief description of the finding and literature support are providedBack to article page